Literature DB >> 26443282

Differential regulation of matrix metalloproteinases in varicella zoster virus-infected human brain vascular adventitial fibroblasts.

Maria A Nagel1, Alexander Choe2, April Rempel2, Ann Wyborny2, Kurt Stenmark3, Don Gilden4.   

Abstract

Upon reactivation, varicella zoster virus (VZV) spreads transaxonally, infects cerebral arteries and causes ischemic or hemorrhagic stroke, as well as aneurysms. The mechanism(s) of VZV-induced aneurysm formation is unknown. However, matrix metalloproteinases (MMPs), which digest extracellular structural proteins in the artery wall, play a role in cerebral and aortic artery aneurysm formation and rupture. Here, we examined the effect of VZV infection on expression of MMP-1, -2, -3, and -9 in primary human brain vascular adventitial fibroblasts (BRAFS). At 6 days post-infection, VZV- and mock-infected BRAFs were analyzed for mRNA levels of MMP-1, -2, -3 and -9 by RT-PCR and for corresponding total intra- and extracellular protein levels by multiplex ELISA. The activity of MMP-1 was also measured in a substrate cleavage assay. Compared to mock-infected BRAFs, MMP-1, MMP-3 and MMP-9 transcripts, cell lysate protein and conditioned supernatant protein were all increased in VZV-infected BRAFs, whereas MMP-2 transcripts, cell lysate protein and conditioned supernatant protein were decreased. MMP-1 from the conditioned supernatant of VZV-infected BRAFs showed increased cleavage activity on an MMP-1-specific substrate compared to mock-infected BRAFs. Differential regulation of MMPs in VZV-infected BRAFs may contribute to aneurysm formation in VZV vasculopathy.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aneurysm; Matrix metalloproteinases; Varicella zoster virus vasculopathy

Mesh:

Substances:

Year:  2015        PMID: 26443282      PMCID: PMC4628845          DOI: 10.1016/j.jns.2015.09.349

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  22 in total

Review 1.  Gelatinase B: a tuner and amplifier of immune functions.

Authors:  G Opdenakker; P E Van den Steen; J Van Damme
Journal:  Trends Immunol       Date:  2001-10       Impact factor: 16.687

2.  Matrix metalloproteinase-9 in cerebral aneurysms.

Authors:  S C Kim; M Singh; J Huang; C J Prestigiacomo; C J Winfree; R A Solomon; E S Connolly
Journal:  Neurosurgery       Date:  1997-09       Impact factor: 4.654

3.  Metalloproteinase-2 and -9 in giant cell arteritis: involvement in vascular remodeling.

Authors:  Alicia Rodríguez-Pla; Josep A Bosch-Gil; José Rosselló-Urgell; Pere Huguet-Redecilla; John H Stone; Miquel Vilardell-Tarres
Journal:  Circulation       Date:  2005-07-05       Impact factor: 29.690

4.  Direct contact between T lymphocytes and monocytes is a major pathway for induction of metalloproteinase expression.

Authors:  S Lacraz; P Isler; E Vey; H G Welgus; J M Dayer
Journal:  J Biol Chem       Date:  1994-09-02       Impact factor: 5.157

5.  Angiotensin II induces an increase in MMP-2 expression in idiopathic ascending aortic aneurysm via AT1 receptor and JNK pathway.

Authors:  Chunmao Wang; Qian Chang; Xiangyang Qian; Chuan Tian; Xiaogang Sun
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2015-06-11       Impact factor: 3.848

6.  Varicella Zoster Virus in Temporal Arteries of Patients With Giant Cell Arteritis.

Authors:  Don Gilden; Maria Nagel
Journal:  J Infect Dis       Date:  2015-07-15       Impact factor: 5.226

7.  Vascular extracellular matrix remodeling in cerebral aneurysms.

Authors:  G Bruno; R Todor; I Lewis; D Chyatte
Journal:  J Neurosurg       Date:  1998-09       Impact factor: 5.115

8.  Varicella-zoster virus vasculopathy: immune characteristics of virus-infected arteries.

Authors:  Maria A Nagel; Igor Traktinskiy; Kurt R Stenmark; Maria G Frid; Alexander Choe; Don Gilden
Journal:  Neurology       Date:  2012-12-12       Impact factor: 9.910

9.  Inhibition of phosphorylated-STAT1 nuclear translocation and antiviral protein expression in human brain vascular adventitial fibroblasts infected with varicella-zoster virus.

Authors:  Maria A Nagel; Stephanie F James; Igor Traktinskiy; Ann Wyborny; Alexander Choe; April Rempel; Nicholas L Baird; Don Gilden
Journal:  J Virol       Date:  2014-07-23       Impact factor: 5.103

10.  Demonstration of interstitial collagenase in abdominal aortic aneurysm disease.

Authors:  E Irizarry; K M Newman; R H Gandhi; G B Nackman; V Halpern; S Wishner; J V Scholes; M D Tilson
Journal:  J Surg Res       Date:  1993-06       Impact factor: 2.192

View more
  6 in total

Review 1.  Varicella zoster virus vasculopathy: The expanding clinical spectrum and pathogenesis.

Authors:  Maria A Nagel; Dallas Jones; Ann Wyborny
Journal:  J Neuroimmunol       Date:  2017-03-18       Impact factor: 3.478

2.  Elevated serum substance P during simian varicella virus infection in rhesus macaques: implications for chronic inflammation and adverse cerebrovascular events.

Authors:  Andrew N Bubak; Vicki Traina-Dorge; Christina N Como; Brittany Feia; Catherine M Pearce; Laura Doyle-Meyers; Arpita Das; Jayme Looper; Ravi Mahalingam; Maria A Nagel
Journal:  J Neurovirol       Date:  2020-09-22       Impact factor: 2.643

3.  Varicella Zoster Virus Vasculopathy.

Authors:  Maria A Nagel; Andrew N Bubak
Journal:  J Infect Dis       Date:  2018-09-22       Impact factor: 5.226

Review 4.  Varicella Zoster Virus in the Nervous System.

Authors:  Don Gilden; Maria Nagel; Randall Cohrs; Ravi Mahalingam; Nicholas Baird
Journal:  F1000Res       Date:  2015-11-26

5.  Targeted RNA Sequencing of VZV-Infected Brain Vascular Adventitial Fibroblasts Indicates That Amyloid May Be Involved in VZV Vasculopathy.

Authors:  Andrew N Bubak; Christina N Como; James E Hassell; Teresa Mescher; Seth E Frietze; Christy S Niemeyer; Randall J Cohrs; Maria A Nagel
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-11-10

6.  Significant Associations of Neurological Complications of Herpes Zoster With Stroke in Rheumatoid Arthritis Patients.

Authors:  Tsai-Ling Liao; Ching-Heng Lin; Hsin-Hua Chen; Yi-Ming Chen; Che-Chen Lin; Der-Yuan Chen
Journal:  J Am Heart Assoc       Date:  2017-07-19       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.